🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: Adult T-cell leukemia/lymphoma (ATLL) and mycosis fungoides/Se...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2020-02-26
Trial ID
NCT04185220
Treatments Being Tested
This is a single center, "modified standard design" dose escalation study d...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2011-09
Trial ID
NCT01385423
Treatments Being Tested
Background: * Recombinant human interleukin-15 (rhIL-15) is a substance th...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2009-11-10
Trial ID
NCT01021059
Treatments Being Tested
This phase I trial studies the side effects and best dose of recombinant in...
Status
Completed
Location
Stanford Cancer Institute Palo Alto
Start Date
2013-02-15
Trial ID
NCT01727076
Treatments Being Tested
Background: -Clear-cell renal cell carcinoma (ccRCC) is a kind of kidney c...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2020-05-26
Trial ID
NCT04150562
BACKGROUND: * Despite progress, some children and young adults with solid ...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2013-06-11
Trial ID
NCT01875601
Treatments Being Tested
Background: Some T-cell lymphomas and leukemias do not respond to standard...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2019-06-07
Trial ID
NCT03905135
Background: Neuroblastoma is a type of cancer that causes tumors in nerves...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2025-10-21
Trial ID
NCT06995872
Treatments Being Tested
Background: Adult T-cell leukemia (ATL) is a rare blood cancer. Researcher...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2017-01-19
Trial ID
NCT02689453
Treatments Being Tested
A phase II trial of CD3/CD19 depleted, IL-15 activated, donor natural kille...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2015-10-01
Trial ID
NCT02395822
Treatments Being Tested